Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ASND
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Ascendis Pharma A/S (ASND) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Ascendis Pharma (ASND) trades at $225.25, down 0.6% on the day, with a bearish technical signal but strong analyst support. The company shows robust revenue growth, with 2025 revenue reaching $720.13 million and a projected net profit margin of 70.84% for 2026, though it remains unprofitable historically. Recent developments include a $400 million share repurchase program and regained rights to TransCon technology in metabolic and cardiovascular diseases, signaling strategic shifts.
The outlook is mixed: strong revenue growth and high analyst buy ratings (92.31%) with a consensus price target of $311.17 suggest upside, but persistent net losses, high debt levels, and bearish technical indicators pose risks. Investors should weigh the potential of approved products against execution challenges and cash flow volatility.
Read full analysis

Key Stats

  • Market Cap
    $14.81B
  • Volume
    586,037
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $196.01
  • Typical Hold Time
    57 Days
  • Enterprise Value
    $14.40B
  • Div Yield
    -
  • Trading Activity
    -
$229.72
52W Low: $196.01
10 Nov 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $196.01 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Most Recent News

Content is generated by Aura AI

Cardinal Infrastructure faces securities fraud probe after Q2 profit margin drop and stock plunge.

The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...

Market News
2 hours ago
Portnoy Law Firm
Bearish
news icon
Cardinal Infrastructure faces securities fraud probe after Q2 profit margin drop and stock plunge.

Orion180 launches FlexLuxe insurance for high-value homes with up to $7.5M coverage in FL and TX

Orion180 Insurance Group has introduced FlexLuxe, a new homeowners insurance product for high-value properties in Florida and Texas, offering up to $5 million dwelling coverage and $7.5 million total insured value. The product features customizable c...

Market News
2 hours ago
Na
Bullish
news icon
Orion180 launches FlexLuxe insurance for high-value homes with up to $7.5M coverage in FL and TX

Novarc unveils advanced AI-powered robotic welding tech at FABTECH 2026 to boost fabrication efficiency.

Novarc Technologies is showcasing its latest robotic welding solutions at FABTECH 2026, featuring the NovAI™ Suite that integrates Physical AI and machine vision for adaptive welding. Their innovations include NovAI Autonomy for real-time weld adjust...

Market News
2 hours ago
Na
Bullish
news icon
Novarc unveils advanced AI-powered robotic welding tech at FABTECH 2026 to boost fabrication efficiency.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $14.81B
  • Volume
    586,037
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $196.01
  • Typical Hold Time
    57 Days
  • Enterprise Value
    $14.40B
  • Div Yield
    -
  • Trading Activity
    -
$229.72
52W Low: $196.01
10 Nov 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $196.01 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!